This site is intended for Healthcare Professionals only.

Type 1 diabetes patients benefit from using flash monitors

Date:

Share post:

Nearly half of Type 1 diabetes patients in the NHS England are benefiting from the use of flash monitors that allow them to check their glucose levels more easily and regularly.

The wearable gadget, linked with a phone app, has a sensor that attaches to the back of the arm, allowing patients to check their glucose with a simple one-second scan.

Eligible patients can access the monitors on prescription from their local GP or diabetes team.

The NHS is ahead of target to roll-out the monitors, as the independent health advisory NICE, confirmed it was beginning the consultation to expand the kit’s access.

As per recent data, around 125,000 patients now uses these monitors to help control their condition. The latest number shows that the NHS significantly exceeded its user target with more than 45 per cent of patients using the monitor.

NHS England’s chief executive, Amanda Pritchard, said: “Flash glucose monitoring is a great example of where technology and digital solutions can help individuals to live more independent lives, better manage their own conditions, and avoid more acute health problems developing.

Dr Partha Kar, NHS England’s national specialty advisor for Diabetes, said: “The high uptake in people with Type 1 diabetes is a clear example of the NHS’ commitment to improving care for people living with this condition and it’s down to the hard work of NHS staff that we’ve managed to roll these out at such a pace, smashing our target of offering to 20% of those eligible by March.”

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue June 2024

Related articles

FIP supports PDA’s Safer Pharmacies Charter

PDA urges all UK pharmacists to take part in the 2024 Safer Pharmacies Survey The International Pharmaceutical Federation...

Topiramate should not be prescribed for epilepsy during pregnancy unless…

MHRA tightens safety measures for topiramate by introducing a new pregnancy prevention programme  Healthcare professionals in the UK are...

WHO issues alert on fake copies of Novo Nordisk’s diabetes drug Ozempic

Falsified batches of Ozempic (semaglutide) were detected in Brazil, the UK, Northern Ireland and the United States The...

Synnovis cyber attack: NHS patient data leaked, services impacted

The NHS has set up helpline number to answer queries and concerns about patient data as Synnovis cyber...